Loading...
•
Sep 30, 2022
Enfusion Q3 2022 Earnings Report
Enfusion's Q3 2022 financial results were announced, demonstrating business momentum and strong execution.
Key Takeaways
Enfusion reported strong financial results for Q3 2022, with total revenue growing to $39.2 million, a 35% increase year-over-year. The company added 43 new clients and saw growth in ARR and NDR. Net income was $2.6 million, and basic and diluted earnings per share were $0.02.
Total revenue grew to $39.2 million, up 35% year-over-year.
ARR for September 2022 was $158.7 million, up 33% year-over-year.
Net Dollar Retention Rate (NDR) excluding involuntary churn was 116.6%.
Added 43 new clients in the third quarter, bringing the total to 810.
Forward Guidance
Enfusion provided guidance for the fourth quarter of 2022, expecting total revenue to be in the range of $39.5 million to $40.5 million and Adjusted EBITDA to be in the range of $5.5 million to $6 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...